Purchase Order 75N91018P00644
Award Date 8/28/18
Potential Completion Date 8/31/19
Potential Value $12K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $23,525.00 on August 20, 2019, for scientific equipment, with performance scheduled through September 30, 2019. Work is performed in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures bioanalytical laboratory instruments including microplate readers, high-content imaging systems, and electrophysiology equipment sold to federal research agencies on a full-and-open,...
- The National Cancer Institute awarded a purchase order to Molecular Devices LLC valued at $3,939.00, with an award date of August 31, 2017 and ultimate completion date of September 29, 2017. The order is firm fixed price with no set-aside. Work is performed in Sunnyvale, California. Molecular Devices is a subsidiary of Danaher Corporation (through Beckman Coulter) and supplies specialized bioanalytical laboratory instruments, including microplate readers, high-content imaging systems, and...
- The National Cancer Institute awarded a purchase order to Molecular Devices LLC on January 29, 2018, for $9,929.00 firm fixed price, with performance in Bethesda, Maryland and completion by January 31, 2019. The order procures specialized bioanalytical laboratory instruments and associated equipment or services within Molecular Devices' core portfolio of microplate readers, high-content imaging systems, electrophysiology equipment, and maintenance support for federal research applications.
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,555 purchase order to Molecular Devices LLC for a service agreement for the SpectroMax i3x plate reader. The contract has a period of performance from December 15, 2023 through December 14, 2024 and utilizes a firm fixed price pricing structure. Molecular Devices LLC will provide plate reader services from its Rockville, Maryland location to support the National Cancer Institute's...
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $24,065.00 on June 28, 2018, with ultimate completion June 28, 2019. No set-aside applies. Place of performance is San Jose, California. The order is firm fixed price for laboratory instruments or related equipment and services, consistent with Molecular Devices' core offerings in bioanalytical instrumentation, imaging systems, and associated maintenance.</p>
- Molecular Devices LLC was awarded a $10,217 firm fixed price purchase order for maintenance services by the National Institutes of Health's National Cancer Institute. The contract has no set-aside designation and work is to be performed in San Jose, California through March 7, 2025. As a provider of bioanalytical measurement solutions, Molecular Devices will support the National Cancer Institute's research efforts through the delivery of maintenance for laboratory instruments and equipment.
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC on December 10, 2019, for a maintenance agreement valued at $14,299.00, with completion by December 31, 2020. Work is performed in San Jose, California. The order covers preventive maintenance and performance assurance services for laboratory instrumentation. No set-aside was used.</p>
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $16,675 on April 20, 2020, for a maintenance agreement with an ultimate completion date of April 29, 2021. Work is performed at the contractor's facility in San Jose, California. The order is firm fixed price with no set-aside designation.</p>
- <p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for a microplate reader on September 22, 2020, with a ceiling value of $24,987.78 and a firm fixed price. Work is performed in San Jose, California, with an ultimate completion date of October 30, 2020. No small business set-aside applies to this order.</p>
- This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for a SERVICE AGREEMENT FOR SPECTRAMAX ID3 PLATE READER, with a ceiling value of $10,932.00 and a period of performance ending on July 14, 2026. The contract has no set-aside designation. Molecular Devices LLC is a manufacturer...